Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

ETR/GS71 stock hub

ETR/GS71 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ETR/GS71is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

85.2B

Deutsche Börse Xetra

Market data

Live price

Current market quote for this ticker.

Current price

ETR/GS71

In the news

Latest news · ETR/GS71

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E9.9

P25 12.3P50 15.7P75 20.2

Trailing P/E12.8

P25 16.4P50 20.9P75 30.4

ROE40.9

P25 -6.7P50 8.5P75 17.2

ROIC26.7

P25 -1.7P50 8.5P75 17.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ETR/GS71 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

237

Groups with data

Currency

GBP

Showing 237 of 237 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	DE
Employees	66,841
Employees Change	-1,583%
Employees Change Percent	-2.25
Enterprise value	EUR 102.8B
Exchange	Deutsche Börse Xetra
Financial currency	GBP
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	GB00BN7SWP63
Last refreshed	2026-05-10
Market cap	EUR 85.2B
Price	EUR 21.43
Price currency	EUR
Rev Per Employee	561,648.41x
Sector	Healthcare
Sic	2834
Symbol	etr/GS71
Website	https://www.gsk.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	7.84%
EV Earnings	15.4x
EV/EBIT	8.97x
EV/EBITDA	7.63x
EV/FCF	14.08x
EV/Sales	2.71x
FCF yield	8.57%
Forward P/E	9.86x
P/B ratio	4.27x
P/E ratio	12.76x
P/S ratio	2.27x
PE Ratio10 Y	90.22x
PE Ratio3 Y	14.7x
PE Ratio5 Y	13.73x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	30.22%
EBITDA Margin	34.88%
FCF margin	19.45%
Gross margin	72.87%
Gross Profit	EUR 27.4B
Gross Profit Growth	5.34%
Gross Profit Growth Q	2.97%
Gross Profit Growth3 Y	5.29%
Gross Profit Growth5 Y	3.18%
Net Income	EUR 6.7B
Net Income Growth	84.87%
Net Income Growth Q	6.96%
Net Income Growth3 Y	-26.44%
Net Income Growth5 Y	2.09%
Pretax Margin	22.69%
Profit Margin	17.78%
Profit Per Employee	EUR 99,873
ROA	10.02
Roa5y	7.23
ROCE	24.49
ROE	40.91
Roe5y	32.1
ROIC	26.7
Roic5y	22.54

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	6.34%
Cagr15y	7.49%
Cagr1y	36.75%
Cagr20y	4.57%
Cagr3y	12.81%
Cagr5y	10.49%
Div CAGR10	-7.64%
Div CAGR3	2.31%
Div CAGR5	-7.52%
EPS Growth	86.56
EPS Growth Q	8.4
EPS Growth3 Y	-26.53
EPS Growth5 Y	1.74
FCF Growth	18.47%
FCF Growth Q	-1.81%
FCF Growth3 Y	19.56%
FCF Growth5 Y	-0.62%
OCF Growth	14.78%
OCF Growth Q	-0.35%
OCF Growth10 Y	11.09%
OCF Growth3 Y	16.34%
OCF Growth5 Y	-0.18%
Revenue Growth	3.97x
Revenue Growth Q	1.5x
Revenue Growth3 Y	4.07x
Revenue Growth5 Y	1.68x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.53
Assets	EUR 72B
Cash	EUR 3.9B
Current Assets	EUR 20.5B
Current Liabilities	EUR 25.9B
Debt	EUR 21.9B
Debt EBITDA	EUR 1.64
Debt Equity	EUR 1.1
Debt FCF	EUR 3
Equity	EUR 20B
Interest Coverage	14.94
Liabilities	EUR 52B
Long Term Assets	EUR 51.5B
Long Term Liabilities	EUR 26.1B
Net Cash	EUR -17.9B
Net Cash By Market Cap	EUR -21.07
Net Debt EBITDA	EUR 1.37
Net Debt Equity	EUR 0.9
Net Debt FCF	EUR 2.46
Tangible Book Value	EUR -8.7B
Tangible Book Value Per Share	EUR -2.16
WACC	5.29

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.79
Inventory Turnover	1.46
Net Working Capital	EUR -3.5B
Quick ratio	0.51
Working Capital	EUR -5.3B
Working Capital Turnover	EUR -10.13

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.13%
Dividend Growth	5.48%
Dividend Growth Years	2%
Dividend per share	EUR 0.76
Dividend Years	26
Dividend Yield	3.56%
Ex Div Date	2026-02-19
Last Dividend	EUR 0.21
Payout Frequency	Quarterly
Payout Ratio	46.91%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	84.97%
1Y total return	36.72%
200-day SMA	20.65
3Y total return	43.58%
50-day SMA	23.63
50-day SMA vs 200-day SMA	50over200
5Y total return	64.66%
All Time High	43.75
All Time High Change	-51.02%
All Time High Date	2001-11-01
All Time Low	13.29
All Time Low Change	61.27%
All Time Low Date	2009-03-25
ATR	0.53
Beta	0.3
Ch YTD	1.85
High	21.43
High52	26.14
High52 Date	2026-02-18
High52ch	-18.02%
Low	21.25
Low52	15.32
Low52 Date	2025-07-18
Low52ch	39.88%
Ma50ch	-9.33%
Price vs 200-day SMA	3.76%
RSI	28.74
RSI Monthly	55.89
RSI Weekly	46.61
Sharpe ratio	1.18x
Sortino ratio	2.16
Total Return	4.69%
Tr YTD	2.67
Tr15y	195.62%
Tr1m	-10.52%
Tr1w	-1.52%
Tr3m	-14.62%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 11.3B
Operating Income Growth	59.89
Operating Income Growth Q	19.83
Operating Income Growth3 Y	10.08
Operating Income Growth5 Y	6.55
Operating margin	30.22

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,864,337,078%
Net Borrowing	616,162,399.1
Shares Insiders	0.07%
Shares Institutions	86.82%
Shares Qo Q	-0.29%
Shares Yo Y	-1.13%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 6.9B
Average Volume	74,887.45x
Bv Per Share	5.09
CAPEX	EUR -1.6B
Ch10y	-6.5
Ch15y	14.67
Ch1m	-10.52
Ch1w	-1.52
Ch1y	31.39
Ch20y	-24.04
Ch3m	-15.3
Ch3y	27.44
Ch5y	7.82
Ch6m	6.35
Change	-0.28%
Change From Open	0.09
Close	21.49
Days Gap	-0.37
Depreciation Amortization	1,766,409,279.2
Dollar Volume	194,563
Earnings Date	2026-04-29
EBIT	EUR 11.3B
EBITDA	EUR 13.1B
EPS	EUR 1.63
F Score	7
FCF	EUR 7.3B
FCF EV Yield	7.1x
Financing CF	-4,891,342,723
Fiscal Year End	December
Founded	1,715
Goodwill	8,423,968,859.5
Graham Number	13.77395
Graham Upside	-35.73
Income Tax	EUR 1.2B
Investing CF	-5,216,592,392
Is Primary Listing	0
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Last Split Date	2022-07-19
Last Split Type	Reverse
Lynch Fair Value	EUR 8.4
Lynch Upside	-60.81
Ma150	21.93
Ma150ch	-2.29%
Ma20	23.35
Ma20ch	-8.23%
Net CF	-1,254,043,616
Next Earnings Date	2026-07-29
Open	21.41
P FCF Ratio	11.66
P OCF Ratio	9.61
Payment Date	2026-04-09
Position In Range	100
Ppne	11,604,199,178.2
Price Date	2026-05-08
Price EBITDA	EUR 6.5
Relative Volume	0.12x
Revenue	37,541,141,295x
SBC By Revenue	1.14x
Share Based Comp	428,321,746
Tax By Revenue	3.3x
Tax Rate	14.54%
Tr20y	144.53%
Tr6m	8.15%
Volume	9,079
Z Score	2.09

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

ETR/GS71 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.6%

$0.76 annual per share

Payout ratio

+46.9%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-7.5%

2 consecutive years of growth

Total shareholder yield

+4.7%

Next ex-dividend date: 2026-02-19

Performance

ETR/GS71 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ETR/GS71?

Insider, institutional, and short-interest positioning.

Institutional ownership

+86.8%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-1.1%

Negative means the company is buying back shares.

Technical

ETR/GS71 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

28.7

Below 30: short-term oversold

Price vs 200-day MA

+3.8%

50/200-day relationship not available

Beta (5Y)

0.30

Less volatile than the market

Sharpe ratio

1.18

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ETR/GS71

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/GS71 stock rating?

etr/GS71 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/GS71 analysis?

The full report lives at /stocks/etr/GS71/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/GS71?

The latest report frames etr/GS71 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/GS71 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.